← Back to Search

Surgery

Robot-Assisted vs Traditional Knee Replacement for Osteoarthritis

N/A
Waitlist Available
Led By Jeremy Reid, MD
Research Sponsored by Virtua Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years postoperatively
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare outcomes of patients who receive traditional total knee replacement surgery to those who receive robot-assisted surgery. The outcomes tracked include: self-reported awareness of their artificial joints during activities of daily living, pain, function in daily living and recreation, knee-related quality of life, general health perceptions, and limb alignment.

Who is the study for?
This trial is for adults over 18 with primary osteoarthritis who need a knee replacement and can follow the study plan. It's not for pregnant women, those without insurance coverage for certain pre-op procedures, or cases related to worker's compensation/personal injury.
What is being tested?
The study compares traditional total knee replacement surgery with robot-assisted surgery by measuring patient comfort, pain levels, daily function, sports activity, quality of life, general health perceptions and accuracy of the surgical procedure.
What are the potential side effects?
While not specified in this summary, typical side effects from knee replacement surgeries may include pain at the site of operation, swelling around the knee joint area, stiffness in the operated leg or difficulty moving.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years postoperatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient reported Forgotten Joint Score (FJS)
Secondary study objectives
Patient reported Knee injury and Osteoarthritis Outcome Score (KOOS)
Patient reported Veterans Rand 12-item Health Survey Score (VR-12)
The mechanical alignment of the post-operative limb

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Robot Assisted Total Knee ReplacementActive Control1 Intervention
In addition to expert judgment and hand-eye coordination, the surgeon also relies on a robot in making cuts within the pre-determined diseased areas of the joints and placing the implants. This is made possible by uploading 3-dimensional (3D) images of the knee joints into the robot prior to surgery. The robot uses these 3D images to guide the surgeon during the procedure. The 3D images are obtained from a computerized tomography (CT) scan that combines a series of X-ray images taken from different angles to create cross-sectional images of the bones.
Group II: Traditional Total Knee ReplacementActive Control1 Intervention
The traditional method where the surgeon employs mechanical guides, expert judgment, and natural hand-eye coordination in making the necessary cuts to prepare the bone for the implant as well as in placing the implant.

Find a Location

Who is running the clinical trial?

Virtua Health, Inc.Lead Sponsor
9 Previous Clinical Trials
439 Total Patients Enrolled
Jeremy Reid, MDPrincipal InvestigatorVirtua Joint Replacement Institute

Media Library

Robot Assisted Total Knee Replacement (Surgery) Clinical Trial Eligibility Overview. Trial Name: NCT03523897 — N/A
Knee osteoarthritis Research Study Groups: Robot Assisted Total Knee Replacement, Traditional Total Knee Replacement
Knee osteoarthritis Clinical Trial 2023: Robot Assisted Total Knee Replacement Highlights & Side Effects. Trial Name: NCT03523897 — N/A
Robot Assisted Total Knee Replacement (Surgery) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03523897 — N/A
Knee osteoarthritis Patient Testimony for trial: Trial Name: NCT03523897 — N/A
~33 spots leftby Nov 2025